The Function of EZH2 in Estrogen Receptor Negative Breast Cancer in Women of Af

EZH2在AF女性雌激素受体阴性乳腺癌中的作用

基本信息

  • 批准号:
    8014602
  • 负责人:
  • 金额:
    $ 35.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-27 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Triple negative (TN) invasive breast carcinomas comprise 10% of breast cancers but result in a large number of deaths, especially among African American women. Characterizing genes that drive these tumors' rapid progression may identify novel biomarkers to guide current treatments, may offer novel therapeutic targets, and decrease health disparities. Although the cellular origin of TN carcinomas is unknown, recent studies strongly suggest that they derive from luminal progenitor cells. We have identified EZH2 as a critical oncogene specifically unregulated in ER negative carcinomas and their metastasis when compared to normal breast tissues. EZH2 expression increases during tumorigenesis and is significantly associated with poor clinical outcome. Of note, EZH2 down regulation in TN breast cancer cell lines decreased their growth in vivo and improved survival. We recently discovered that EZH2 over expression expands the tumorigenic stem cell population with a specific increase in the number of luminal progenitors in a Notchi-depedent manner. Our Central Hypothesis is that dysregulated expression of EZH2 promotes TN breast carcinogenesis by increasing the breast stem cell population, particularly the luminal progenitors. We further hypothesize that EZH2 expression and detection of luminal progenitors may be novel biomarkers of metastasis and prognosis in TN invasive carcinomas from Caucasian, African American, and West African women. Our aims are: Aim 1. To elucidate the role of EZH2 in the maintenance of stem cells and luminal progenitors that give rise to TN invasive carcinomas; and Aim 2. To assess the clinical utility of EZH2 over expression and detection of luminal progenitors as biomarkers of survival in TN invasive carcinomas from Caucasian, African American, and West African women . This proposal combines the use of unique, well-annotated human tissues from Caucasian, African-American, and West-African patients from Ghana with in vivo and in vitro models of TN breast carcinoma. Our goal is that the functional characterization of EZH2 in TN breast cancer will identify a new pathway driving these aggressive tumors, and allow tailored treatment and perhaps targeted intervention to prevent the development of metastases.
描述(由申请人提供):三阴性(TN)浸润性乳腺癌占乳腺癌的10%,但导致大量死亡,尤其是在非洲裔美国妇女中。表征驱动这些肿瘤快速进展的基因可以识别新的生物标志物来指导当前的治疗,可以提供新的治疗靶点,并减少健康差异。虽然TN癌的细胞起源是未知的,最近的研究强烈建议,他们来自管腔祖细胞。我们已经确定EZH 2作为一个关键的癌基因,特别是在ER阴性癌及其转移相比,正常乳腺组织中不受调节。EZH 2表达在肿瘤发生期间增加,并且与不良临床结果显著相关。值得注意的是,TN乳腺癌细胞系中的EZH 2下调降低了它们的体内生长并改善了存活率。我们最近发现,EZH 2的过度表达扩大了致瘤干细胞群,并以Notchi依赖的方式特异性增加了管腔祖细胞的数量。我们的中心假设是EZH 2的表达失调通过增加乳腺干细胞群,特别是管腔祖细胞来促进TN乳腺癌的发生。我们进一步假设EZH 2表达和管腔祖细胞的检测可能是来自高加索人、非洲裔美国人和西非妇女的TN浸润性癌的转移和预后的新生物标志物。我们的目标是:目标1。阐明EZH 2在维持引起TN浸润性癌的干细胞和管腔祖细胞中的作用;以及评估EZH 2过表达和管腔祖细胞检测作为高加索人、非裔美国人和西非妇女TN浸润性癌生存期生物标志物的临床效用。该建议结合使用独特的,注释良好的人类组织从高加索人,非洲裔美国人,和西非患者从加纳在体内和体外模型TN乳腺癌。我们的目标是,EZH 2在TN乳腺癌中的功能表征将确定驱动这些侵袭性肿瘤的新途径,并允许定制治疗和可能的靶向干预,以防止转移的发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Celina G Kleer其他文献

Celina G Kleer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Celina G Kleer', 18)}}的其他基金

The Function of EZH2 in Estrogen Receptor Negative Breast Cancer in Women of Af
EZH2在AF女性雌激素受体阴性乳腺癌中的作用
  • 批准号:
    8532854
  • 财政年份:
    2010
  • 资助金额:
    $ 35.37万
  • 项目类别:
The Function of EZH2 in Estrogen Receptor Negative Breast Cancer in Women of Af
EZH2在AF女性雌激素受体阴性乳腺癌中的作用
  • 批准号:
    8149926
  • 财政年份:
    2010
  • 资助金额:
    $ 35.37万
  • 项目类别:
The Function of EZH2 in Estrogen Receptor Negative Breast Cancer in Women of Af
EZH2在AF女性雌激素受体阴性乳腺癌中的作用
  • 批准号:
    8307505
  • 财政年份:
    2010
  • 资助金额:
    $ 35.37万
  • 项目类别:
The Function of EZH2 in Estrogen Receptor Negative Breast Cancer in Women of Af
EZH2在AF女性雌激素受体阴性乳腺癌中的作用
  • 批准号:
    8707400
  • 财政年份:
    2010
  • 资助金额:
    $ 35.37万
  • 项目类别:
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer
CCN6 (WISP3) 在乳腺癌进展和转移中的作用
  • 批准号:
    8305594
  • 财政年份:
    2008
  • 资助金额:
    $ 35.37万
  • 项目类别:
Role of CCN6 (WISP3) in the Progression and Metastasis of Breast Cancer.
CCN6 (WISP3) 在乳腺癌进展和转移中的作用。
  • 批准号:
    8777055
  • 财政年份:
    2008
  • 资助金额:
    $ 35.37万
  • 项目类别:
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer
CCN6 (WISP3) 在乳腺癌进展和转移中的作用
  • 批准号:
    7529379
  • 财政年份:
    2008
  • 资助金额:
    $ 35.37万
  • 项目类别:
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer
CCN6 (WISP3) 在乳腺癌进展和转移中的作用
  • 批准号:
    10447058
  • 财政年份:
    2008
  • 资助金额:
    $ 35.37万
  • 项目类别:
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer
CCN6 (WISP3) 在乳腺癌进展和转移中的作用
  • 批准号:
    10676901
  • 财政年份:
    2008
  • 资助金额:
    $ 35.37万
  • 项目类别:
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer
CCN6 (WISP3) 在乳腺癌进展和转移中的作用
  • 批准号:
    7903858
  • 财政年份:
    2008
  • 资助金额:
    $ 35.37万
  • 项目类别:

相似海外基金

Broadening Participation Research: Understanding faculty attitudes, competency, and perceptions of providing career advising to African American STEM students at HBCUs
扩大参与研究:了解教师对 HBCU 的非裔美国 STEM 学生提供职业建议的态度、能力和看法
  • 批准号:
    2306671
  • 财政年份:
    2023
  • 资助金额:
    $ 35.37万
  • 项目类别:
    Continuing Grant
Cognitive Behavioral Faith-based Depression Intervention For African American Adults (CB-FAITH): An Effectiveness And Implementation Trial
非裔美国成年人基于认知行为信仰的抑郁干预 (CB-FAITH):有效性和实施试验
  • 批准号:
    10714464
  • 财政年份:
    2023
  • 资助金额:
    $ 35.37万
  • 项目类别:
DELINEATING THE ROLE OF THE HOMOCYSTEINE-FOLATE-THYMIDYLATE SYNTHASE AXIS AND URACIL ACCUMULATION IN AFRICAN AMERICAN PROSTATE TUMORS
描述同型半胱氨酸-叶酸-胸苷酸合成酶轴和尿嘧啶积累在非裔美国人前列腺肿瘤中的作用
  • 批准号:
    10723833
  • 财政年份:
    2023
  • 资助金额:
    $ 35.37万
  • 项目类别:
Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness-based Stress Reduction for Justice-Involved Black/African American Female Adolescents and Parents/Caregivers
探索创伤后应激障碍 (PTSD) 症状、障碍和促进因素,为涉及正义的黑人/非裔美国女性青少年和父母/照顾者进行基于正念的减压
  • 批准号:
    10593806
  • 财政年份:
    2023
  • 资助金额:
    $ 35.37万
  • 项目类别:
Preventing Firearm Suicide Deaths Among Black/African American Adults
防止黑人/非裔美国成年人因枪支自杀死亡
  • 批准号:
    10811498
  • 财政年份:
    2023
  • 资助金额:
    $ 35.37万
  • 项目类别:
BCSER - PVEST: A Dynamic Framework for Investigating STEM Interest, Attitude and Identity Among African American Middle School Students
BCSER - PVEST:调查非裔美国中学生 STEM 兴趣、态度和身份的动态框架
  • 批准号:
    2327055
  • 财政年份:
    2023
  • 资助金额:
    $ 35.37万
  • 项目类别:
    Standard Grant
Making the Connection: Understanding the dynamic social connections impacting type 2 diabetes management among Black/African American men
建立联系:了解影响黑人/非裔美国男性 2 型糖尿病管理的动态社会联系
  • 批准号:
    10782674
  • 财政年份:
    2023
  • 资助金额:
    $ 35.37万
  • 项目类别:
Building a Community-Based Mental Health Literacy Intervention for African American Young Adults
为非裔美国年轻人建立基于社区的心理健康素养干预措施
  • 批准号:
    10738855
  • 财政年份:
    2023
  • 资助金额:
    $ 35.37万
  • 项目类别:
African American Literature in "post" Post-Racial America
“后”后种族美国中的非裔美国文学
  • 批准号:
    23K00376
  • 财政年份:
    2023
  • 资助金额:
    $ 35.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Impact of a Race-Based Stress Reduction Intervention on Well-Being, Inflammation, and DNA methylation in Older African American Women at Risk for Cardiometabolic Disease
基于种族的减压干预措施对有心血管代谢疾病风险的老年非洲裔美国女性的健康、炎症和 DNA 甲基化的影响
  • 批准号:
    10633624
  • 财政年份:
    2023
  • 资助金额:
    $ 35.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了